首页> 外文期刊>Clinical, Cosmetic and Investigational Dermatology >A randomized, placebo-controlled, single-blinded, split-faced clinical trial evaluating the efficacy and safety of KLOX-001 gel formulation with KLOX light-emitting diode light on facial rejuvenation
【24h】

A randomized, placebo-controlled, single-blinded, split-faced clinical trial evaluating the efficacy and safety of KLOX-001 gel formulation with KLOX light-emitting diode light on facial rejuvenation

机译:评估KLOX-001凝胶制剂与KLOX发光二极管灯对面部嫩肤的功效和安全性的随机,安慰剂对照,单盲,双面板临床试验

获取原文
       

摘要

Purpose: Many treatment modalities exist to counteract the effects of cutaneous aging. Ablative methods have been the mainstay for nonsurgical facial rejuvenation. In recent years, nonablative techniques have been developed with the aim of achieving facial rejuvenation without epidermal damage. Light-emitting diode (LED) photorejuvenation is a novel nonablative technique that induces collagen synthesis through biophotomodulatory pathways. Materials and methods: A single-center, randomized, single-blinded, placebo-controlled, split-faced clinical trial was designed. Thirty-two patients were enrolled for a 12-week study. Patients were randomized into one of four groups: Group A, treatment with KLOX-001 gel formulation and white LED (placebo) light; Group B, treatment with a placebo/base gel (no active chromophore) formulation and KLOX LED light; Group C, treatment with KLOX-001 gel formulation and KLOX LED light; and Group D, treatment with the standard skin rejuvenating treatment (0.1% retinol-based cream). Patients received treatment at weeks 0, 1, 2, and 3, and returned to the clinic at weeks 4, 8, and 12 for clinical assessments performed by an independent, blinded committee of physicians using subjective clinician assessment scales. Tolerability, adverse outcomes, and patient satisfaction were also assessed. Results: Analysis demonstrated that the KLOX LED light with KLOX placebo/base gel and the KLOX LED light + KLOX-001 gel formulation groups were superior to standard of care and KLOX-001 gel formulation with placebo light on subjective clinical assessment and multiple wrinkle scales, with statistically significant results obtained for brow positioning, perioral wrinkling, and total wrinkle score. Conclusion: The study results show that KLOX LED light with KLOX-001 gel formulation and KLOX LED light with KLOX placebo/base gel are effective, safe, well-tolerated, and painless treatment modalities for skin rejuvenation.
机译:目的:存在许多治疗方法以抵消皮肤衰老的影响。消融方法一直是非手术面部修复的主要手段。近年来,已经开发了非消融技术,其目的是在不损害表皮的情况下实现面部修复。发光二极管(LED)光子嫩化是一种新颖的非烧蚀技术,可通过生物光调节途径诱导胶原合成。材料和方法:设计了单中心,随机,单盲,安慰剂对照,两面的临床试验。 32名患者参加了为期12周的研究。患者被随机分为四组:A组,用KLOX-001凝胶制剂和白色LED(安慰剂)灯治疗; A组。 B组,用安慰剂/基础凝胶(无活性发色团)制剂和KLOX LED灯治疗; C组,用KLOX-001凝胶制剂和KLOX LED灯治疗; D组,用标准的嫩肤疗法(0.1%视黄醇基霜)进行治疗。患者在第0、1、2和3周接受治疗,并在第4、8和12周返回诊所,由独立的盲人医师委员会使用主观临床医师评估量表进行临床评估。还评估了耐受性,不良后果和患者满意度。结果:分析表明,在主观临床评估和多种皱纹尺度上,带有KLOX安慰剂/基础凝胶的KLOX LED灯和带有LOLO-LED灯+ KLOX-001凝胶配方的组均优于带有安慰剂的KLOX-001凝胶配方的护理标准。 ,在眉毛定位,口周皱纹和总皱纹得分方面具有统计学意义。结论:研究结果表明,采用KLOX-001凝胶配方的KLOX LED灯和采用KLOX安慰剂/基础凝胶的KLOX LED灯是有效的,安全的,耐受性良好且无痛的皮肤修复方法。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号